221 related articles for article (PubMed ID: 18245736)
1. Action plan for emerging molecular imaging technologies.
McEwan AJ; Van Brocklin HF; Divgi C
J Nucl Med; 2008 Feb; 49(2):37N-40N. PubMed ID: 18245736
[No Abstract] [Full Text] [Related]
2. The uncertain path to the future of imaging biomarkers.
Nunn AD
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):96-8. PubMed ID: 17420711
[No Abstract] [Full Text] [Related]
3. Nuclear medicine applications in molecular imaging: 2007 update.
Blankenberg FG; Strauss HW
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):99-110. PubMed ID: 17420712
[TBL] [Abstract][Full Text] [Related]
4. Working together to create the future.
Pappas V
J Nucl Med; 2008 Mar; 49(3):18N. PubMed ID: 18322114
[No Abstract] [Full Text] [Related]
5. SNM 2006 Scientific Program explores expanding imaging technologies.
J Nucl Med; 2006 Mar; 47(3):16N. PubMed ID: 16594105
[No Abstract] [Full Text] [Related]
6. How much CT is needed in nuclear medicine.
Shah C; Patton JA; Sandler MP
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1759-60. PubMed ID: 18542958
[No Abstract] [Full Text] [Related]
7. Multimodality molecular imaging with combined optical and SPECT/PET modalities.
Culver J; Akers W; Achilefu S
J Nucl Med; 2008 Feb; 49(2):169-72. PubMed ID: 18199608
[TBL] [Abstract][Full Text] [Related]
8. Advancing molecular imaging from the laboratory to everyday practice.
VanBrocklin HF
J Nucl Med; 2008 Dec; 49(12):22N-23N. PubMed ID: 19038993
[No Abstract] [Full Text] [Related]
9. Molecular imaging in China: looking back and forward.
Wagner HN
J Nucl Med; 2008 Dec; 49(12):19N-21N. PubMed ID: 19038991
[No Abstract] [Full Text] [Related]
10. Future of nuclear medicine: SPECT versus PET.
Gholamrezanejhad A; Mirpour S; Mariani G
J Nucl Med; 2009 Jul; 50(7):16N-18N. PubMed ID: 19652221
[No Abstract] [Full Text] [Related]
11. SNM molecular imaging summit introduces clinical trials network.
McEwan AS; Graham MM; Conti PS
J Nucl Med; 2009 Apr; 50(4):18N. PubMed ID: 19339670
[No Abstract] [Full Text] [Related]
12. Role of in vivo imaging of the central nervous system for developing novel drugs.
Rueger MA; Kracht LW; Hilker R; Thiel A; Sobesky J; Winkeler A; Thomas AV; Heneka MT; Graf R; Herholz K; Heiss WD; Jacobs AH
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):164-81. PubMed ID: 17420717
[TBL] [Abstract][Full Text] [Related]
13. A look back at a year of extraordinary success and forward to a rewarding future.
McEwan AJ
J Nucl Med; 2008 Jun; 49(6):80N-81N. PubMed ID: 18511840
[No Abstract] [Full Text] [Related]
14. Radiolabelled chemotherapeutics.
Rottey S; Signore A; Van de Wiele C
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):139-51. PubMed ID: 17420715
[TBL] [Abstract][Full Text] [Related]
15. SPET: sustainable, powerful, effective, timely in vivo molecular imaging.
Lucignani G
Q J Nucl Med Mol Imaging; 2005 Jun; 49(2):117-20. PubMed ID: 16010249
[No Abstract] [Full Text] [Related]
16. [Morphological, functional and molecular imaging with hybrid systems].
Bartenstein P; Rist C; Reiser MF
Radiologe; 2010 Apr; 50(4):327-8. PubMed ID: 20217036
[No Abstract] [Full Text] [Related]
17. Nuclear medicine 2020.
Strauss HW
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):1-3. PubMed ID: 16557198
[No Abstract] [Full Text] [Related]
18. Multidisciplinary care and emerging technologies: optimizing patient care or truce in a turf battle?
Rose CM
J Am Coll Radiol; 2004 Sep; 1(9):624-5. PubMed ID: 17411668
[No Abstract] [Full Text] [Related]
19. Small-animal preclinical nuclear medicine instrumentation and methodology.
Rowland DJ; Cherry SR
Semin Nucl Med; 2008 May; 38(3):209-22. PubMed ID: 18396180
[TBL] [Abstract][Full Text] [Related]
20. Molecular imaging.
Maggi A; Salvatore M
Q J Nucl Med Mol Imaging; 2007 Jun; 51(2):95. PubMed ID: 17420710
[No Abstract] [Full Text] [Related]
[Next] [New Search]
